About the Emerging Therapeutic Modalities Session
Emerging therapeutic modalities are reshaping the landscape of cancer treatment. Techniques like CAR-T cell therapy, gene editing technologies such as CRISPR, and epigenetic drugs are expanding the arsenal against cancer. These approaches tackle disease at its genetic and molecular roots, offering personalized solutions. Additionally, novel platforms like oncolytic viruses and bispecific antibodies are gaining traction for their ability to target tumors while activating the immune system. The ongoing integration of these therapies into clinical practice signals a new era in oncology, with potential to improve survival rates significantly.
Topics Covered in Emerging Therapeutic Modalities
CAR-T Cell Therapy
CRISPR Gene Editing
Epigenetic Drugs
Oncolytic Viruses
Bispecific Antibodies
Targeted Protein Degraders
Related Scientific Sessions at CIOC 2027
Why Attend the Emerging Therapeutic Modalities Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Emerging Therapeutic Modalities work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Emerging Therapeutic Modalities research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Emerging Therapeutic Modalities track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Emerging Therapeutic Modalities Conference 2027 — FAQs
What is the Emerging Therapeutic Modalities track at CIOC 2027?
The Emerging Therapeutic Modalities track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Emerging Therapeutic Modalities. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Emerging Therapeutic Modalities sessions?
Cancer researchers and clinicians, educators and students with an interest in Emerging Therapeutic Modalities are all welcome — whether presenting or attending.
Can I present my research in the Emerging Therapeutic Modalities track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Emerging Therapeutic Modalities sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Emerging Therapeutic Modalities track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.